Objective: To investigate the relationship between the metabolic syndrome and intraocular pressure (IOP). Methods: An observational study was conducted in a medical health checkup program at a general hospital. This study involved 14 003 apparently healthy Japanese men and women, 18-83 years of age, with a mean IOP of 14.8 (3.0) mm Hg. IOP was examined by noncontact tonometer. High-ocular tension was defined as IOP 421 mm Hg without optic-disc abnormalities or history of receiving any anti-glaucoma therapy. Modified criteria of the revised National Cholesterol Education Program Adult Treatment Panel III (rATPIII), the new International Diabetes Federation definition, and the Japan Society for The Study of Obesity definition were used to characterize the metabolic syndrome. Air temperature was assessed from the Gifu Meteorological Observatory, Gifu, Japan. Results: In the male and female subjects, mean IOP and the prevalence of high-ocular tension became high in direct correlation with the increased number of metabolic syndrome components. To analyze by logistic regression, the metabolic syndrome defined by rATPIII was positively and maximum temperature was negatively correlated with high-ocular tension in males (adjusted odds ratio: 2.0 [95% confidence interval, CI, 1.43-2.78] and 0.63 [95% CI, 0.54-0.73], respectively) and in females (adjusted odds ratio: 7.09 [95% CI, 3.74-13.43] and 0.67 [95% CI, 0.53-0.87], respectively). Three of five metabolic syndrome components (fasting plasma glucose, blood pressure, and triglycerides) were related to high-ocular tension.
Introduction
The metabolic syndrome is a collection of risk factors that increase a person's chance of developing heart disease, stroke, and diabetes. The original description of the metabolic syndrome by Reaven consisted of factors including obesity, insulin resistance, hypertension, impaired glucose tolerance or diabetes, hyperinsulinemia, and dyslipidemia characterized by elevated triglyceride, and low high-density lipoprotein (HDL) concentrations. 1 It affects a great number of people worldwide, and the prevalence of this syndrome increases with age. Some studies estimate the current prevalence in the United States to be up to 25% of the population, 2 and among native Japanese to be 41% (range:
19-60%) in men and 51% (range: 31-89%) in women. 3 As our understanding of the action of insulin evolves to comprehensively include the recent insulin-related discoveries, 4 it becomes easier to see that insulin resistance is the basis of most, if not all, of the features of the metabolic syndrome. The original conceptualization of the metabolic syndrome was on the basis of resistance to the metabolic actions of insulin. 5 Ocular hypertension (OH) is one of the major risk factors of primary open angle glaucoma. 6, 7 OH is the state in which intraocular pressure (IOP) is 421 mm Hg, the anterior chamber angle is open, and both optic-disc abnormality and visual-field defect are not detectable. Meanwhile, glaucoma is a type of optic neuropathy, and glaucoma patients suffer from a decrease in the quality of vision, which causes a progressive visual-field defect.
An earlier study has shown that the mean IOP value tends to increase linearly according to the number of risk factors for the metabolic syndrome. 8 However, the relationship between the metabolic syndrome and OH is unknown. We designed a cross-sectional study in a healthy Japanese population to examine the possibility of an association between high-ocular tension, which represents OH in this study, and the metabolic syndrome.
Materials and methods

Study design
We performed a cross-sectional study involving participants of a medical health checkup program, including abdominal ultrasonography and IOP measurement. The study was approved by the ethics committee of Murakami Memorial Hospital, Gifu, Japan. The program was conducted in the Medical Health Checkup Center at Murakami Memorial Hospital. The purpose of the medical health checkup program is to promote public health through early detection of chronic diseases and the evaluation of their underlying risk factors. Known as a 'human dock,' medical services of this kind are very popular in Japan.
Study population
All of the subjects participating in such health checkup programs at Murakami Memorial Hospital between January 2004 and December 2008 were invited to join this study. This study was approved by the ethics committee of Murakami Memorial Hospital. Participants who reported earlier ophthalmic anti-glaucoma therapy or surgery, or the use of steroid drugs were excluded from this study. In addition, participants who reported the use of any drugs, which could influence the metabolic syndrome such as anti-diabetic drugs, anti-hypertensive drugs, anti-dyslipidemic drugs, anti-goat drugs, and/or anti-obesity drugs, were also excluded from the main analysis, but were used in a subgroup analysis. In the main analysis, we assessed the direct effects of the metabolic syndrome and its components on IOP. In the subgroup analysis, we assessed whether the participants who had well-controlled abnormal metabolic profiles because of medication had a decreased risk of highocular tension. In this study, all participants who reported the use of any drugs were categorized as the 'medication group.' Those participants discontinued their use of the medication on the day when they received the health check up.
Data collection
The health checkup programs that were used for the collection of data in this study included the following tests: eye examinations, urinalysis, blood-cell counts, blood chemistry, electrocardiography, chest radiography, barium examination of the upper gastrointestinal tract, and abdominal ultrasonography. Trained technicians, hepatologists, and radiologists conducted the abdominal ultrasonography, and hepatologists or radiologists diagnosed the ultrasonographic findings in the Japanese 'human dock.' Ophthalmologic specialists performed the eye examinations. High-ocular tension was defined as right-eye IOP of 421 mm Hg without optic-disc abnormalities or history of receiving any antiglaucoma therapy. The medical history and lifestyle factors of all participants, including physical activity and habits pertaining to smoking and alcohol consumption, were surveyed by use of a self-administered questionnaire. When the participants had difficulty completing the questionnaire, trained nurses provided assistance. We undertook blood and urine examinations with MODULAR ANALYTICS (Hitachi High-Technologies Corp., Ltd, Tokyo, Japan). Body mass index was calculated as body weight in kilograms divided by the square of the participant's height in meters. The eye examinations consisted of visual acuity, IOP measurement between 9-and 10-o'clock AM by noncontact tonometry (TOPCON CT-90A; TOPCON Corp., Tokyo, Japan) and fundus photography (TOPCON TRC-NW200; TOPCON Corp.) with no mydriasis. Three successive IOP measurements per eye were averaged and the values of right-eye IOP were adopted. Weather parameters were obtained from the Gifu Meteorological Observatory, Gifu, Japan.
Metabolic syndrome
There are several differing criteria for the metabolic syndrome worldwide. [9] [10] [11] [12] [13] [14] In this study, we used the following three definitions for metabolic syndrome: (1) (X100 mg per 100 ml). The Japan Society for The Study of Obesity, as well as study conducted by Matuzawa, another Japanese researcher, recommended the following four abnormalities to define the metabolic syndrome in Japan: (1) abdominal obesity (abdominal circumference X85 cm for men and X90 cm for women); (2) elevated serum triglyceride level (X150 mg per 100 ml) and/or decreased HDL cholesterol level (o40 mg per 100 ml); (3) elevated blood pressure (systolic blood pressure X130 mm Hg and/or diastolic blood pressure X85 mm Hg); and (4) an elevated fasting glucose level (X110 mg per 100 ml). Of the four abnormalities listed above, subjects with (1) plus two or more of (2) through (4) were considered to have the metabolic syndrome. 14 
Sample size
As the prevalence of high-ocular tension in persons with the metabolic syndrome was unknown, a formal sample size estimate was not made a priority in this study.
Statistical methods
The R version 2.4.1 (available from http://www.r-project.org/) was used for statistical analyses. Data was expressed as mean (s.d.). Two groups of subjects were compared by using the unpaired t-test and the w 2 test, and a P-value of o0.05 was accepted as a significant level. The difference of continuous variable between two groups among multiple groups was analyzed by one-way analysis of variance followed by the Tukey's Honestly Significantly Different test. We analyzed the association of the number of components of the metabolic syndrome with IOP by using a linear regression model. Logistic regression was used to analyze associations between the incidence of high-ocular tension and the metabolic syndrome while controlling for other parameters such as age, duration of sunshine, and maximum temperature. The adjusted odds ratio and 95% confidence intervals (CIs) were calculated.
Results
Between January 2004 and December 2008, we invited 20 012 participants in the health checkup program to enroll in the study. Of those, a total of 16 929 Japanese participants (10 124 men and 6805 women) were enrolled after giving informed consent to be included in the study. We excluded 841 participants (527 men and 314 women) who reported earlier ophthalmic anti-glaucoma therapy or surgery, or usage of steroid drugs. Moreover, 2085 participants (1566 men and 519 women) who reported the use of any drugs, which could influence the metabolic syndrome such as antidiabetic drugs, anti-hypertensive drugs, anti-dyslipidemic drugs, anti-goat drugs, and/or anti-obesity drugs, were used for a subgroup analysis (medication group). As a result, this study ultimately consisted of 14 003 apparently healthy participants (8031 men and 5972 women). The mean age was 46.0 years (s. 49.0-145.0 cm) in women, respectively. Among the medication group, the mean age, body mass index, and abdominal circumference were significantly higher than those among the main group of analyzed subjects group (Table 1) .
High-ocular tension was detected in 2.4% of the apparently healthy males (95% CI, 2.0-2.7%) (n ¼ 190 of 8031 subjects) and in 1.1% of the apparently healthy females (95% CI, 0.8-1.3%) (n ¼ 65 of 5972 subjects). The prevalence of high-ocular tension was higher in the males than in the females (Po0.001).
The metabolic syndrome defined by rATPIII was detected in 15.3% of the apparently healthy males (95% CI, 14.5-16.1%) (n ¼ 1226 of 8031 subjects) and in 5.1% of the apparently healthy females (95% CI, 4.6-5.7%) (n ¼ 306 of 5972 subjects) ( Table 1) . High-ocular tension was detected in 2.1% of the males without the metabolic syndrome defined by rATPIII (95% CI, 1.7-2.4%) (n ¼ 140 of 6805 subjects) and in 0.9% of the females without it (95% CI, 6.7-11.8%) (n ¼ 51 of 5666 subjects). High-ocular tension was detected in 4.1% of the apparently healthy males with the metabolic syndrome defined by rATPIII (95% CI, 3.0-5.3%) (n ¼ 50 of 1226 subjects) and in 4.6% of the apparently healthy females with it (95% CI, 2.5-7.6%) (n ¼ 14 of 306 subjects). The prevalence of high-ocular tension was higher in males and in females with the metabolic syndrome than in those without it (Po0.001). The metabolic syndrome defined by IDF was detected in 8.2% of the apparently healthy males (95% CI, 7.6-8.8%) (n ¼ 655 of 8031 subjects) and in 4.3% of the apparently healthy females (95% CI, 3.8-4.8%) (n ¼ 256 of 5972 subjects) ( Table 1) .
As the definitions of metabolic syndrome used in this study require information about drug medication, we compared the IOP between metabolic syndrome participants who were free from medication and those who were receiving medication. By using three definitions of the metabolic syndrome, we separated 9597 males and 6491 females into four groups according to the absence or presence of Metabolic syndrome and high-ocular tension K Imai et al metabolic syndrome and medication. When participants satisfied the criteria for metabolic syndrome, the prevalence of high-ocular tension was up to 2.9-4.1% of the apparently healthy males, and up to 4.6-11.4%, the apparently healthy females (Table 2) . On the other hand, when participants did not satisfy the criteria for metabolic syndrome, the prevalence of high-ocular tension was down to 2.1-2.3% of the apparently healthy males, and down to 0.9-1.0% of the apparently healthy females. High-ocular tension was detected in 3.9-5.0% of the males and in 1.7-2.7% of the females who were diagnosed as metabolic syndrome and received medication. The mean IOP was at the same level, with and without medication, when participants satisfied the criteria of metabolic syndrome. The mean IOP was higher in participants who were diagnosed as metabolic syndrome than in those who were not diagnosed as metabolic syndrome, despite the use of medication. When participants received medication, but were not metabolic Metabolic syndrome and high-ocular tension K Imai et al syndrome, the mean IOP was lower than in those metabolic syndrome participants who were free from medication. Next, we separated participants into four groups as follows to assess the effect of medication and controlling states: (1) participants who were under the criterion and were free from medication, (2) participants who were over the criterion and were free from medication, (3) participants who were under the criterion controlled by medication, and (4) participants who were over criterion despite of medication (Table 3) . IOP was higher in participants whose blood sugar level was over the criterion. The medication and controlling states for blood sugar was found to have no effect on IOP. When we turned our attention toward blood pressure and triglycerides, we discovered that IOP was lower in participants whose levels were controlled within the criteria by medication than in those who had not received medication. On the other hand, HDL criterion was found to be not associated with IOP, regardless of whether the participants received medication or not, or whether the participants satisfied the criterion or not.
As for the main analysis, we analyzed 14 003 apparently healthy participants (8031 men and 5972 women) to assess the direct effects of the metabolic syndrome and its components on IOP. Linear regression analysis indicated an association between the average IOP and the number of components of the metabolic syndrome, both in males (b ¼ 0.17, Po0.001) and females (b ¼ 0.13, Po0.001). We calculated the odds ratio of the metabolic syndrome, age, smoking habits, and temperature for high-ocular tension using a logistic model ( Table 4 ). The rATPIII-defined metabolic syndrome was a statistically significant explanatory variable both in males (odds ratio: 2.02, 95% CI, 1.46-2.81) and females (odds ratio: 5.28, 95% CI, 2.89-9.64). The Japan Society for The Study of Obesity-defined metabolic syndrome was also a statistically significant explanatory variable both in males (odds ratio: 2.02, 95% CI, 1.46-2.81) and females (odds ratio: 5.28, 95% CI, 2.89-9.64). However, the IDF-defined metabolic syndrome was not a statistically significant explanatory variable in males. One of the reasons for that was the fact that increased waist circumference was not a statistically significant explanatory variable in males. Temperature was a negative explanatory variable.
From the univariate logistic model, we selected age, maximum temperature, and the existence of the rATPIIIdefined metabolic syndrome, or the number of its components, or each criterion as an explanatory variable in the multivariate logistic analyses. We applied three models of multivariate logistic analyses to investigate the association of high-ocular tension with the metabolic syndrome (Table 5) . In Model 1, each component of the metabolic syndrome, including increased abdominal circumference, elevated fasting glucose level, elevated blood pressure, decreased HDL Metabolic syndrome and high-ocular tension K Imai et al cholesterol level, and elevated triglyceride level, was listed as independent variables. Model 2 replaced the diagnosis of the metabolic syndrome in Model 1 with the number of metabolic syndrome components. In Model 3, each component of the metabolic syndrome was switched to the diagnosis of metabolic syndrome.
In both males and females, high-ocular tension was correlated positively with the metabolic syndrome and Abbreviations: HDL, high-density lipoprotein; IDF, the new International Diabetes Federation definition; JASSO, the Japan Society for the Study of Obesity; MS, the metabolic syndrome; rATPIII, the revised National Cholesterol Education Program Adult Treatment Panel III definition. Univariate logistic analysis was applied for high-ocular tension in 8031 males and 5972 females. Data was expressed as the odds ratio (95% confidence interval). The odds of the number of components mean the odds ratio of one component. For age and temperatures, the odds of 1 s.d. for high-ocular tension were expressed. Abbreviations: HDL, high-density lipoprotein; MS, the metabolic syndrome; rATPIII, the revised National Cholesterol Education Program Adult Treatment Panel III definition. Multivariate logistic analysis was applied for high-ocular tension in 8031males and 5972 females. Data was expressed as the odds ratio (95% confidence interval). The odds of the number of components mean the odds ratio of one component. For age and temperatures, the odds of 1 s.d. for high-ocular tension were expressed.
Metabolic syndrome and high-ocular tension K Imai et al negatively with maximum temperature. There was also a significantly positive relationship between the number of metabolic syndrome components and high-ocular tension. When each component of the metabolic syndrome was analyzed, elevated fasting glucose level, elevated blood pressure, elevated triglyceride level, and maximum temperature were found to be significantly associated with highocular tension both in males and females.
To clarify the effect of the other two components, increased abdominal circumference and decreased HDL cholesterol level, for high-ocular tension, we categorized the subjects into one of the two groups. The first group included subjects who satisfied none of the three criteria such as elevated fasting glucose level, elevated blood pressure, and elevated triglyceride level. The second group included subjects who satisfied at least one of these three criteria.
The prevalence of high-ocular tension was not increased in subjects who had increased abdominal circumference and/or a decreased HDL cholesterol level among each subgroup (Figure 1) 
Discussion
Principal findings
In this study, we showed the association between rATPIIIdefined metabolic syndrome and both IOP and high-ocular tension. It has been reported that subjects with more metabolic syndrome components had higher IOP. 8 However,
we found that IDF-defined metabolic syndrome was not linked to high-ocular tension in males. IDF is different from rATPIII in that increased waist circumference is not one of the components, but is needed to conduct a proper Figure 1 When each component of the metabolic syndrome was analyzed, three of the five metabolic syndrome components (fasting plasma glucose, blood pressure, and triglycerides) were found to be related to high-ocular tension. The study subjects were then categorized into one of the two groups. The first group (a, b) included subjects who satisfied none of the three criteria such as elevated fasting glucose level, elevated blood pressure, and elevated triglyceride level. The second group (c, d) included subjects who satisfied at least one of these three criteria. Figures indicate the prevalence of subjects with high-ocular tension among subjects with increased abdominal circumference and/or decreased HDL cholesterol level, and those with high-ocular tension among subjects with normal abdominal circumference and normal HDL cholesterol level. Two groups of subjects were compared by using the w 2 test, and Po0.05 was accepted as the significant level.
Metabolic syndrome and high-ocular tension K Imai et al diagnosis. Therefore, we also evaluated which components of the metabolic syndrome are related to high-ocular tension. Interestingly, this study showed that three of the five components (fasting plasma glucose, blood pressure, and triglycerides) were associated with high-ocular tension and that the other two were not.
We also assessed the participants who were receiving medication as a subgroup analysis. The subgroup analysis indicated that IOP was higher in participants who were diagnosed as having metabolic syndrome, whether they were receiving medication or not. When we assessed the effect of medication and the controlling states for each component of the metabolic syndrome, the control for blood pressure or triglycerides level by medication decreased the IOP. However, the medication for plasma glucose did not present this phenomenon.
Limitations of the study High-ocular tension is a concept that is included in health checkup programs, yet it is not necessarily equivalent to OH. To diagnose OH, additional evaluations including slit-lamp examination and a visual-field test are required, yet they were not performed because of economical and temporal reasons. IOP was measured by noncontact tonometer. When comparing the noncontact tonometer with the Goldmann applanation tonometer, the noncontact tonometer showed a slightly higher IOP reading, but still close to those obtained with the Goldmann applanation tonometer. 16 Other limitations may include complications arising from un-measured factors such as central corneal thickness (CCT) or other known risk factors for higher IOP. It should be noted that the results of the subgroup analysis that showed that the medication for blood pressure or triglycerides could decrease IOP still requires validation by a future longitudinal study.
Interpretation
Several earlier studies showed that the rise of IOP is associated with diabetes mellitus and systemic hypertension, 17, 18 whereas other studies have reported no association. 19 The multivariate analysis in this study indicates the correlation between high-ocular tension and both hyperglycemia and systemic hypertension in both males and females. Although the mechanism behind how hyperglycemia affects IOP is unclear, it has been reported that there is possibly more than one effect and that some effects may operate in opposite directions. 20 It has been suggested that the cause of the rise in IOP in systemic hypertension is the excessive production of aqueous humor or the increase of episcleral vein pressure. 21 The positive relationship between IOP and total cholesterol has been reported, 17 whereas to the best of our knowledge, the association between IOP and the other lipid metabolisms have not been well discussed. In our multivariate data, triglycerides were correlated with highocular tension. One possible reason for this is that hypertriglyceridemia is commonly associated with diabetes and obesity. Higher IOP has also been found to be related to obesity, 17, 22 probably because of excess intraorbital fat tissue and an increase in viscosity of the blood, which consequently decreases outflow facility. 23 Individually, three components of the metabolic syndrome, fasting plasma glucose, blood pressure, and triglycerides, do not affect IOP elevation to a large degree, but when taken into consideration as a whole, they do affect the development of high-ocular tension. Therefore, we suspect that a common background exists between high-ocular tension and the metabolic syndrome. As mentioned above, the increase in episcleral venous pressure, which is caused by excess orbital fat, may occur with the decrease of outflow facility. Episcleral venous pressure also increases the insulin resistance mechanism, which has been found in an earlier study to induce the retension of sodium when extracellular fluid volume is expanded. 24 Recent studies have suggested that higher glucose 25 and the number of metabolic syndrome components 26 were associated with thicker CCT. The mean CCT of the participants with metabolic syndrome who met the three components was 6 mm thicker than that of paticipants without metabolic syndrome. 26 Murase et al. 27 reported that a 10 mm increase in CCT led to an IOP 0.29 mm Hg higher when measured with a noncontact tonometer. Accordingly, the influence of CCT to IOP in the metabolic syndrome participants who met the three components was calculated at almost 0.17 mm Hg, whereas the difference of mean IOP between participants with no component and participants with three components was 1.4 mm Hg in this study. We consider CCT to be merely one of the factors that elucidate high IOP in the metabolic syndrome. Numerous studies have reported that there are seasonal variations of IOP and that in winter, IOP rises more than in summer. 17, 28 Our results also indicate that maximal temperature is negatively related to the occurrence of high-ocular tension. These phenomena show that IOP is affected by the endogenous rhythm. 28 
Conclusion
The prevalence of metabolic syndrome was associated with high-ocular tension, which represents OH in this study. The high IOP related to the metabolic syndrome is not desirable in patients with not only OH, but also normal tension glaucoma. It has been reported that primary open angle glaucoma develops from 1 to 2% of OH cases every year 7 and that the higher IOP the patients have, the greater possibility they have of developing primary open angle glaucoma. However, an earlier report has shown that normal tension glaucoma makes up 90% of Japanese primary open angle glaucoma cases. 29 Even when IOP is in the normal range, the Metabolic syndrome and high-ocular tension K Imai et al risk of the progression of visual-field defect in normal tension glaucoma increases 10% with each 1 mm Hg rise in IOP. 30 Therefore, it is important to keep the metabolic syndrome in mind as a consideration when managing IOP. To improve glaucoma treatment in patients with the metabolic syndrome, those patients should be provided with instruction on how to lessen their metabolic syndrome component levels. The medication for blood pressure or triglycerides could decrease high IOP, which often accompanies the metabolic syndrome. However, this possibility requires validation by a future longitudinal study.
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